|
SLC38A6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.16110000187342E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92403000000008E-05 |
| Normal-vs-Stage2 |
1.216510E-03 |
| Normal-vs-Stage3 |
1.837810E-04 |
| Normal-vs-Stage4 |
5.772100E-04 |
| Stage1-vs-Stage2 |
4.760800E-01 |
| Stage1-vs-Stage3 |
7.370200E-01 |
| Stage1-vs-Stage4 |
7.803600E-01 |
| Stage2-vs-Stage3 |
7.109200E-01 |
| Stage2-vs-Stage4 |
3.902000E-01 |
| Stage3-vs-Stage4 |
5.616800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34760000053613E-07 |
| Normal-vs-AfricanAmerican |
3.280100E-02 |
| Normal-vs-Asian |
3.765700E-02 |
| Caucasian-vs-AfricanAmerican |
3.853800E-01 |
| Caucasian-vs-Asian |
2.828600E-01 |
| AfricanAmerican-vs-Asian |
7.740000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3673999994851E-07 |
| Normal-vs-Female |
8.44650000000335E-05 |
| Male-vs-Female |
2.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.312970E-01 |
| Normal-vs-Age(41-60Yrs) |
3.50599999998646E-06 |
| Normal-vs-Age(61-80Yrs) |
2.42349999999281E-05 |
| Normal-vs-Age(81-100Yrs) |
2.801100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.554200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.514600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.400400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.817600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.159800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.139800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.064400E-01 |
| Normal-vs-Grade 2 |
2.48489999998824E-06 |
| Normal-vs-Grade 3 |
8.2505000000066E-05 |
| Normal-vs-Grade 4 |
1.618490E-03 |
| Grade 1-vs-Grade 2 |
9.313400E-01 |
| Grade 1-vs-Grade 3 |
9.484400E-01 |
| Grade 1-vs-Grade 4 |
9.996000E-01 |
| Grade 2-vs-Grade 3 |
6.649800E-01 |
| Grade 2-vs-Grade 4 |
8.527000E-01 |
| Grade 3-vs-Grade 4 |
8.912800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.22139999999494E-05 |
| Normal-vs-ccB subtype |
1.68656999999239E-05 |
| ccA subtype-vs-ccB subtype |
1.492830E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31960000038234E-07 |
| Normal-vs-N1 |
8.563600E-01 |
| N0-vs-N1 |
1.054840E-01 |
|
|
